Other 5-Ht1 Agonists has 7 known drug interactions based on U.S. FDA drug labeling data. Of these, 7 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Eletriptan Hydrobromide, Rizatriptan, Rizatriptan Benzoate. Patients taking Other 5-Ht1 Agonists should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Contraindicated
- 7
Contraindicated (7)
- Other 5-Ht1 Agonists + Eletriptan Hydrobromide— Concomitant use of other 5-HT1 agonists is contraindicated within 24 hours of eletriptan treatment.
- Other 5-Ht1 Agonists + Rizatriptan— Co-administration within 24 hours is contraindicated due to additive vasospastic effects.
- Other 5-Ht1 Agonists + Rizatriptan Benzoate— Co-administration of other 5-HT1 agonists with rizatriptan within 24 hours is contraindicated due to additive vasospasti…
- Other 5-Ht1 Agonists + Sumatriptan— Coadministration of sumatriptan and other 5-HT1 agonists (triptans) within 24 hours is contraindicated due to additive v…
- Other 5-Ht1 Agonists + Sumatriptan Succinate— Co-administration of sumatriptan with other 5-HT1 agonists within 24 hours is contraindicated due to additive vasospasti…
- Other 5-Ht1 Agonists + Sumatriptan Succinate And Naproxen Sodium— 5-HT1 agonists cause vasospastic effects. Coadministration with other triptans within 24 hours is contraindicated due to…
- Other 5-Ht1 Agonists + Zolmitriptan— Concomitant use within 24 hours increases risk of additive vasospastic reactions. Use is contraindicated.